You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Use of targeted next generation sequencing to characterize tumor mutational burden and efficacy of immune checkpoint inhibition in small cell lung cancer

Article metrics

Article menu

Download PDFPDF

XML
Research Article
Use of targeted next generation sequencing to characterize tumor mutational burden and efficacy of immune checkpoint inhibition in small cell lung cancer

 

Online download statistics by month:

Online download statistics by month: December 2019 to July 2025

AbstractFullPdf
Dec 2019330
Jan 202011116
Feb 202028284
Mar 202026261
Apr 2020141411
May 202018184
Jun 202023235
Jul 202022227
Aug 202081817
Sep 202038389
Oct 2020313112
Nov 2020242418
Dec 202021219
Jan 2021323227
Feb 2021131310
Mar 202113137
Apr 2021181811
May 2021222222
Jun 2021323216
Jul 2021252513
Aug 202112127
Sep 2021313125
Oct 2021212128
Nov 2021282827
Dec 2021384111
Jan 202223257
Feb 2022262610
Mar 2022141822
Apr 2022283516
May 2022202114
Jun 2022292913
Jul 2022373715
Aug 202226289
Sep 2022212515
Oct 2022232712
Nov 2022292918
Dec 2022313111
Jan 202315157
Feb 2023202213
Mar 2023505223
Apr 2023191912
May 2023232411
Jun 202326267
Jul 2023313113
Aug 2023232312
Sep 202324245
Oct 202320215
Nov 202318186
Dec 2023282912
Jan 202418194
Feb 202419199
Mar 202427279
Apr 2024181911
May 202487876
Jun 2024272815
Jul 202428298
Aug 2024191912
Sep 2024262613
Oct 2024292914
Nov 202425269
Dec 202422228
Jan 2025333313
Feb 20252122197
Mar 2025272715
Apr 202556562
May 202568688
Jun 202519199
Jul 2025110
Total17991839947